Cart (0 Items)
Your cart is currently empty.
View Products
| Size | 100ug |
|---|---|
| Brand | ProteoGenix |
| Product type | Recombinant Proteins |
| Host Species | Mammalian cells |
| Applications | Elisa, WB |
| Product name | Human CD72 (Lys221-Asp359) recombinant protein |
|---|---|
| Uniprot ID | P21854 |
| Uniprot link | https://www.uniprot.org/uniprot/Q01973 |
| Origin species | Homo sapiens (Human) |
| Expression system | Eukaryotic expression |
| Molecular weight | 43.4 kDa |
| Protein delivered with Tag? | C-terminal His Tag |
| Purity estimated | >85% by SDS-PAGE |
| Buffer | PBS, pH7.5 |
| Delivery condition | Dry Ice |
| Delivery lead time in business days | Europe: 5-7 working days USA & Canada: 7-10 working days Rest of the world: 5-12 working days |
| Storage condition | 4°C for short term (1 week), -20°C or -80°C for long term (avoid freezing/thawing cycles; addition of 20-40% glycerol improves cryoprotection) |
| Brand | ProteoGenix |
| Host species | Mammalian cells |
| Fragment Type | Lys221-Asp359 |
| Aliases /Synonyms | Lyb-2, Lyb2 |
| Reference | PX-P6003 |
| Note | For research use only |
Human CD72 (Lys221-Asp359) is a recombinant protein consisting of 139 amino acids. It is a single-chain, glycosylated protein that is synthesized in a prokaryotic expression system. It has an approximate molecular weight of 15.3 kDa.
Human CD72 (Lys221-Asp359) is an immunoglobulin superfamily member that binds to B-cell receptors and modulates B-cell activation. It also plays a role in the regulation of B-cell differentiation and proliferation.
Human CD72 (Lys221-Asp359) has potential applications in drug target discovery and protein-based therapeutics. It can be used to identify novel drug targets and to develop drugs and therapies for diseases related to B-cell activation.
Send us a message from the form below
Reviews
There are no reviews yet.